The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast
Abstract
Aims : Cytokeratin (CK) 14, a myoepithelial marker, is also expressed in a proportion of breast carcinomas. There is evidence that these tumours show a differing metastatic pattern and clinical outcome from other invasive ductal carcinomas (IDCs) and may need different management. Currently, they are not identified in routine practice and no morphological guidelines exist to aid their identification. The aim of this study was to analyse the histological features of CK14+ IDC. Methods and results : A detailed histological review of 453 grade 3 IDCs revealed 88 (19.4%) that expressed CK14. Assessment was made independently by two pathologists using a standardized ‘tick‐box’ proforma covering grade, architectural and cytological features. The results were analysed using logistic regression to identify features that predicted for basal phenotype. Concordance between the two pathologists was fair to good for most parameters (κ 0.4–0.6). On multiple logistic regression, the basal phenotype was highly significantly associated with the presence of a central scar (P = 0.005), tumour necrosis (P < 0.0001), presence of spindle cells (P = 0.006) or squamous metaplasia (P < 0.0001), high total mitotic count (> 40 per 10 high‐power field) (P = 0.0002) and high nuclear–cytoplasmic ratio (P = 0.0002). Conclusions : Specific morphological features are strongly associated with basal‐like breast carcinoma. These could be used in routine diagnostic practice to identify this important subset of tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Foulkes, W. D. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg050 · Cited by 970
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
van der Groep, P., Bouter, A., van der Zanden, R., Menko, F. H., Buerger, H., Verheijen, R. H. M., van der Wall, E., & van Diest, P. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh114 · Cited by 798
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Self-citationLakhani, S. R., Reis-Filho, J. S., Fulford, L., Penault-Llorca, F., van der Vijver, M., Parry, S., Bishop, T., Benitez, J., Rivas, C., Bignon, Y.-J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2424 · Cited by 611
Self-citationExpression of luminal and basal cytokeratins in human breast carcinoma
Abd El‐Rehim, D. M., Pinder, S. E., Paish, C. E., Bell, J., Blamey, R., Robertson, J. F., Nicholson, R. I., & Ellis, I. O. (2004) · The Journal of Pathology · doi:10.1002/path.1559 · Cited by 594
van de Rijn, M., Perou, C. M., Tibshirani, R., Haas, P., Kallioniemi, O., Kononen, J., Torhorst, J., Sauter, G., Zuber, M., Köchli, O. R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64476-8 · Cited by 560
Medullary carcinoma of the breast.A clinicopathologic study with 10 year follow-up
Ridolfi, R. L., Rosen, P. P., Port, A., Kinne, D., & Miké, V. (1977) · Cancer · doi:10.1002/1097-0142(197710)40:4<1365::aid-cncr2820400402>3.0.co;2-n · Cited by 424
Gusterson, B. A., Warburton, M. J., Mitchell, D., Ellison, M., Neville, A. M., & Rudland, P. S. (1982) · PubMed · Cited by 290
Nagle, R. B., Böcker, W., Davis, J. R., Heid, H. W., Kaufmann, M., Lucas, D. O., & Jarasch, E. D. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.7.2423579 · Cited by 270
Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. S., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Venter, D. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n · Cited by 259
Matos, I., Dufloth, R., Alvarenga, M., Zeferino, L. C., & Schmitt, F. (2005) · Virchows Archiv · doi:10.1007/s00428-005-0010-7 · Cited by 227
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
Laakso, M., Loman, N., Borg, Å., & Isola, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800456 · Cited by 190
Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels, R. H. W., Kuijpers, H. J. H., Lane, E. B., Leigh, I. M., Troyanovsky, S. M., Holland, R., van Haelst, U. J. G. M., & Ramaekers, F. C. S. (1991) · PubMed Central · Cited by 183
Malzahn, K., Mitze, M., Thoenes, M., & Moll, R. (1998) · Virchows Archiv · doi:10.1007/s004280050226 · Cited by 174
Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer
Arnes, J. B., Brunet, J.-S., Stefansson, I., Bégin, L. R., Wong, N., Chappuis, P. O., Akslen, L. A., & Foulkes, W. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2064 · Cited by 158
Jones, C., Ford, E., Gillett, C., Ryder, K., Merrett, S., Reis-Filho, J. S., Fulford, L. G., Hanby, A. M., & Lakhani, S. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0731 · Cited by 139
Self-citationGould, V. E., Koukoulis, G. Κ., Jansson, D. S., Nagle, R. B., Franke, W. W., & Moll, R. (1990) · Europe PMC (PubMed Central) · Cited by 95
Gillett, C., Miles, D. W., Ryder, K., Skilton, D., Liebman, R., Springall, R. J., Barnes, D. M., & Hanby, A. M. (2001) · The Journal of Pathology · doi:10.1002/path.831 · Cited by 95
Self-citationComedonecrosis is an unfavorable marker in node‐negative invasive breast carcinoma
Yagata, H., Harigaya, K., Suzuki, M., Nagashima, T., Hashimoto, H., Ishii, G., Miyazaki, M., Nakajima, N., & Mikata, A. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01514.x · Cited by 18
Cited by
Basal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164
Self-citationEpithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Triple negative tumours: a critical review
Reis‐Filho, J. S., & Tutt, A. N. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02889.x · Cited by 884
Self-citationTriple-Negative Breast Cancer: An Unmet Medical Need
Hudis, C. A., & Gianni, L. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-01 · Cited by 780
Yang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., Gaudet, M., Schmidt, M. K., Broeks, A., Cox, A., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq526 · Cited by 691
Self-citation
Metadata
- Authors
- Fulford, L. G., Easton, D. F., Reis‐Filho, J. S., Sofronis, A., Gillett, C. E., Lakhani, S. R., & Hanby, A.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2006-06-27
- Volume
- 49
- Issue
- 1
- Pages
- 22-34
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W1973807269
- Cited by
- 352
- References
- 25
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.